Archive: 30/09/2013
Alcohol leaving the UK charts with a hangover
Are we allowing alcohol marketing to children and teens via the music they love? As many as one in five songs in the UK top ten today include references to alcohol—a figure rising partly due to US-imported songs. What impact ...
Sep 30, 2013
Trial combining anti-cancer drug and radiotherapy may lead to treatment for brain tumor
Results from a clinical trial of a new treatment for glioblastoma suggest that researchers may have found a new approach to treating this most aggressive of brain tumours, as well as a potential new biological marker than ...
Sep 30, 2013
First estimate of amount of radiotherapy dose wasted in compensating for tumour growth between treatments
For the first time, researchers have estimated the daily dose of radiotherapy that could be wasted in compensating for cancer cell growth that occurs overnight and during weekends in patients with early breast cancer.
Sep 30, 2013
New research shows how aspirin may act on blood platelets to improve survival in colon cancer patients
Researchers believe they have discovered how aspirin improves survival in patients diagnosed with colon cancer, the 2013 European Cancer Congress (ECC2013) [1] heard today (Monday).
Sep 30, 2013
Biological therapy with cediranib improves survival in women with recurrent ovarian cancer
Women with ovarian cancer that has recurred after chemotherapy have survived for longer after treatment with a biological therapy called cediranib, according to new results to be presented today (Monday) at the 2013 European ...
Sep 30, 2013
Olympians say poor oral health is impairing performance
Many of the elite sportsmen and women who competed at the London 2012 Olympic Games had poor levels of oral health similar to those experienced by the most disadvantaged populations. 18 per cent of athletes surveyed said ...
Sep 30, 2013
Identifying the disease-causing mechanisms in cancers with unknown primary site improves treatment
Identifying the molecular profile of a tumour where the primary site is unknown is crucial to the choice of treatment, the 2013 European Cancer Congress (ECC2013) [1], will hear on Monday. In up to five percent of all cancers, ...
Sep 30, 2013
New approaches to testing cancer drugs needed
Research institutes, regulators and the pharmaceutical industry are urged to cooperate to develop new approaches to testing cancer drugs, in order to bring the revolution in personalised medicine to patients across Europe, ...
Sep 30, 2013